ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Paradoxical Association Between Baseline Apolipoprotein B and Prognosis in Coronary Artery Disease: A 36,460 Chinese Cohort Study

Li, Huanqiang; Wang, Bo; Mai, Ziling; Yu, Sijia; Zhou, Ziyou; Lu, Hongyu; Lai, Wenguang; Li, Qiang; Yang, Yongquan; Deng, Jingru; Tan, Ning; Chen, Jiyan; Liu, Jin*; Liu, Yong; Chen, Shiqun广东省人民医院; 广东省心血管病研究所; 南方医科大学; y
Frontiers in Cardiovascular Medicine2022-1-25DOI: 10.3389/fcvm.2022.822626
1被引12阅读
引用收藏
分享

摘要

BackgroundApolipoprotein B (ApoB) and low-density lipoprotein cholesterol (LDL-C) were identified targets for blood lipid management among coronary artery disease (CAD) patients. However, previous studies reported an inverse correlation between baseline LDL-C concentration and clinical outcomes. This study aims to explore the definite association between baseline ApoB and long-term prognosis. MethodsA total of 36,460 CAD patients admitted to Guangdong Provincial People's Hospital were enrolled and categorized into two groups: high ApoB (>= 65 mg/dL) group and low ApoB (<65 mg/dL) group. The association between baseline ApoB and long-term all-cause mortality was evaluated by the Kaplan-Meier method, Cox regression analyses and restricted cubic splines. ResultsThe overall mortality was 12.49% (n = 4,554) over a median follow-up period of 5.01 years. Patients with low baseline ApoB levels were paradoxically more likely to get a worse prognosis. There was no obvious difference in risk of long-term all-cause mortality when only adjusted for age, gender, and comorbidity (aHR: 1.07, 95% CI: 0.99-1.16). When CONUT and total bilirubin were adjusted, the risk of long-term all-cause mortality would reduce in the low-ApoB (<65 mg/dL) group (aHR: 0.86, 95% CI: 0.78-0.96). In the fully covariable-adjusted model, patients in the ApoB <65 mg/d group had a 10.00% lower risk of long-term all-cause mortality comparing to patients with ApoB >= 65 mg/dL (aHR: 0.90; 95% CI:0.81-0.99). ConclusionThis study found a paradoxical association between baseline ApoB and long-term all-cause mortality. Malnutrition and bilirubin mainly mediate the ApoB paradox. Increased ApoB concentration remained linearly associated with an increased risk of long-term all-cause mortality.

学科与关键词

关键词
apolipoprotein Bcoronary artery diseaselong-term prognosisall-cause mortalityparadox
相关
加载中…
  • Non-HDL cholesterol paradox and effect of underlying malnutrition in patients with coronary artery disease: A 41,182 cohort study
    Wang, Bo; Guo, Zhaodong; Li, Huanqiang; Zhou, Ziyou; Lu, Hongyu; Ying, Ming; Mai, Ziling; Yu, Yaren; Yang, Yongquan; Deng, Jingru; Chen, Jiyan; Tan, Ning; Liu, Jin*; Liu, Yong*; Chen, Shiqun*CLINICAL NUTRITION, 2022, 41(3): 723-730.被引 5
  • Malnutrition affects cholesterol paradox in coronary artery disease: a 41,229 Chinese cohort study
    Wang, Bo; Liu, Jin; Chen, Shiqun; Ying, Ming; Chen, Guanzhong; Liu, Liwei; Lun, Zhubin; Li, Huanqiang; Huang, Haozhang; Li, Qiang; Yu, Yaren; Lin, Mengfei; Wei, Wen; Huang, Zhidong; Yang, Yongquan; Chen, Jiyan; Tan, Ning*; Liu, Yong*Lipids in Health and Disease, 2021, 20(1): 36.被引 24
  • Association of apolipoprotein B with all-cause and cardiovascular mortality among adults: Results from the National Health and Nutrition Examination Surveys
    Yan, Meng-qi; Huang, Yu; Liu, Xiao-cong; Chen, Chao -lei; Zhou, Dan; Huang, Yu-qing; Feng, Ying-qing*American Journal of the Medical Sciences, 2023, 366(5): 367-373.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cardiovascular Medicine
发表日期
2022-01-25
卷期
第 9 卷
页码
822626
DOI
10.3389/fcvm.2022.822626
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81670339, 81970311]; Beijing Lisheng Cardiovascular Health Foundation [LHJJ20141751]; National Key Research and Development Program of China [2016YFC1301202]; Guangdong Provincial People's Hospital Dengfeng Project Fund [DFJH201919, DFJH2020026]

作者

  • L

    Li, Huanqiang (第一作者)

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • W

    Wang, Bo

    guangdong cardiovasc inst · guangdong prov peoples hosp

查看全部 15 位作者收起作者
  • M

    Mai, Ziling

    guangdong prov peoples hosp · guangdong cardiovasc inst

  • Y

    Yu, Sijia

    guangdong cardiovasc inst · guangdong prov peoples hosp · 2 · southern med univ

  • Z

    Zhou, Ziyou

    guangdong prov peoples hosp · guangdong cardiovasc inst

  • L

    Lu, Hongyu

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • L

    Lai, Wenguang

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • L

    Li, Qiang

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • Y

    Yang, Yongquan

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • D

    Deng, Jingru

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • T

    Tan, Ning

    guangdong prov peoples hosp · guangdong cardiovasc inst · 2 · southern med univ

  • C

    Chen, Jiyan

    guangdong cardiovasc inst · guangdong prov peoples hosp · 2 · southern med univ

  • L

    Liu, Jin (通讯)

    2 · southern med univ · guangdong prov peoples hosp · guangdong cardiovasc inst

  • L

    Liu, Yong

    guangdong cardiovasc inst · guangdong prov peoples hosp · 2 · southern med univ

  • C

    Chen, Shiqun

    guangdong cardiovasc inst · guangdong prov peoples hosp · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417